Social Prescribing for a Mindful Lifestyle
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorBuddhist Tzu Chi General Hospital
About this trial
The goal of this clinical trial is to evaluate the effectiveness of an 8-week mindfulness lifestyle social prescribing program in community-dwelling older adults aged 55 and older. The main questions it aims to answer are:
To establish a mindfulness lifestyle social prescribing model applied to the psychological and social health promotion of middle-aged and older populations.
To evaluate the effectiveness of the intervention on improving depressive symptoms, loneliness, and quality of life in this population.
Participants will receive an 8-week group intervention program, with each weekly session lasting approximately 3 hours. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). Researchers will collect and evaluate data from pre- and post-intervention assessments to measure changes in depressive symptoms, loneliness risk, and overall quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
People aged 55 years or older.
People with a Geriatric Depression Scale (GDS-15) score of 7-10 or a UCLA Loneliness Scale Version 3 score of 35-64.
People can understand the research process, meet the requirements of the research, and can sign the informed consent and participate in the project.
Disqualifiers
People that are unable to cooperate with the project or follow-up.
According to the PI's judgment, people with severe or poorly controlled conditions include ongoing acute diseases, severe infections, severe abnormal laboratory tests, or serious medical conditions with the following systems: cardiovascular, pulmonary, hepatic, nervous, mental, metabolic, renal, musculoskeletal, gastrointestinal, etc.
People with severe depression, risk of self-harm, severe cognitive impairment (dementia), visual or hearing impairment, and disabilities that prevent the completion of the project and assessment.
People are currently or expected to join any other physical training courses or nutrition intervention plans during the project period.
Trial design
Design model
Single group
Treatments tested in this trial
Mindfulness Lifestyle Social Prescribing Program
BehavioralAn 8-week, once-weekly, 3-hour group program designed for middle-aged and older adults. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). It is delivered by a multidisciplinary team including geriatricians, case managers, dietitians, exercise instructors, and volunteers.
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Experimental ArmExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Changes in Geriatric Depression Scale (GDS-15) score
The Geriatric Depression Scale (GDS-15) is a 15-item questionnaire used to assess depression symptoms in older adults. Scores range from 0 to 15, with higher scores indicating more severe depressive symptoms.
Time frame
Baseline and Week 82
Changes in UCLA Loneliness Scale score
The UCLA Loneliness Scale measures an individual's subjective feelings of loneliness and social isolation. Scores range from 20 to 80, with higher scores indicating greater loneliness.
Time frame
Baseline and Week 83
Changes in WHOQOL-BREF questionnaire score
The World Health Organization Quality of Life-BREF (WHOQOL-BREF) Taiwan version is a 28-item questionnaire used to assess the physical, psychological, social relationships, and environment domains of quality of life. Scores for each domain are transformed to a scale of 4 to 20, with higher scores indicating better quality of life. Changes in scores were evaluated between baseline and week 8.
Time frame
Baseline and Week 8Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov